192 related articles for article (PubMed ID: 26161545)
21. Enhancing innovation between scientific and indigenous knowledge: pioneer NGOs in India.
Torri MC; Laplante J
J Ethnobiol Ethnomed; 2009 Oct; 5():29. PubMed ID: 19849851
[TBL] [Abstract][Full Text] [Related]
22. A Delphi Technology Foresight Study: Mapping Social Construction of Scientific Evidence on Metagenomics Tests for Water Safety.
Birko S; Dove ES; Özdemir V
PLoS One; 2015; 10(6):e0129706. PubMed ID: 26066837
[TBL] [Abstract][Full Text] [Related]
23. BT Slingsby: driving forward innovation in global health.
Kirby T
Lancet Infect Dis; 2015 Mar; 15(3):274. PubMed ID: 25749234
[No Abstract] [Full Text] [Related]
24. The ethics of sequencing infectious disease pathogens for clinical and public health.
Johnson SB; Parker M
Nat Rev Genet; 2019 Jun; 20(6):313-315. PubMed ID: 30874624
[No Abstract] [Full Text] [Related]
25. Non-governmental organizations in international health: past successes, future challenges.
Gellert GA
Int J Health Plann Manage; 1996; 11(1):19-31. PubMed ID: 10157062
[TBL] [Abstract][Full Text] [Related]
26. Biomedicine, public health, and citizenship in the advent of antiretrovirals in Botswana.
Chabrol F
Dev World Bioeth; 2014 Aug; 14(2):75-82. PubMed ID: 24720398
[TBL] [Abstract][Full Text] [Related]
27. New strategies for innovation in global health: a pharmaceutical industry perspective.
Witty A
Health Aff (Millwood); 2011 Jan; 30(1):118-26. PubMed ID: 21209447
[TBL] [Abstract][Full Text] [Related]
28. It's a matter of values: partnership for innovative change.
Herbert C; Best A
Healthc Pap; 2011; 11(2):31-7; discussion 64-7. PubMed ID: 21677515
[TBL] [Abstract][Full Text] [Related]
29. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
30. State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global context.
Salter B; Faulkner A
Global Health; 2011 Feb; 7():3. PubMed ID: 21349182
[TBL] [Abstract][Full Text] [Related]
31. [One health, one world].
Wildner M
Gesundheitswesen; 2014 Mar; 76(3):125-6. PubMed ID: 24664957
[No Abstract] [Full Text] [Related]
32. Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.
Subotnik RF; Olszewski-Kubilius P; Worrell FC
Psychol Sci Public Interest; 2011 Jan; 12(1):3-54. PubMed ID: 26168418
[TBL] [Abstract][Full Text] [Related]
33. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
34. Multi-Dimensional Impact of the Public-Private Center for Translational Molecular Medicine (CTMM) in the Netherlands: Understanding New 21(st) Century Institutional Designs to Support Innovation-in-Society.
Steuten LM
OMICS; 2016 May; 20(5):265-73. PubMed ID: 27195965
[TBL] [Abstract][Full Text] [Related]
35. [The complexity of medical organizations in the 21st century].
Afek A; Meilik A; Rotstein Z
Harefuah; 2009 Feb; 148(2):121-4, 138. PubMed ID: 19627042
[TBL] [Abstract][Full Text] [Related]
36. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
37. Mental health system development profiles and indicators of scientific and technology innovation.
Vilela Chaves C; Moro S
J Ment Health Policy Econ; 2009 Jun; 12(2):67-78. PubMed ID: 19567932
[TBL] [Abstract][Full Text] [Related]
38. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
Abuduxike G; Aljunid SM
Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
[TBL] [Abstract][Full Text] [Related]
39. Vaccine research, development, and innovation in Brazil: a translational science perspective.
Homma A; Tanuri A; Duarte AJ; Marques E; de Almeida A; Martins R; Silva-Junior JB; Possas C
Vaccine; 2013 Apr; 31 Suppl 2():B54-60. PubMed ID: 23598493
[TBL] [Abstract][Full Text] [Related]
40. The clinical benefits, ethics, and economics of stratified medicine and companion diagnostics.
Trusheim MR; Berndt ER
Drug Discov Today; 2015 Dec; 20(12):1439-50. PubMed ID: 26542060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
